Stay updated on Odanacatib Study in Adolescents Clinical Trial
Sign up to get notified when there's something new on the Odanacatib Study in Adolescents Clinical Trial page.

Latest updates to the Odanacatib Study in Adolescents Clinical Trial page
- Check7 days agoChange DetectedThe page now clearly states that recruitment is closed for this study (no longer looking for participants). New help and navigation items have been added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label formatting has been updated, and the site revision has been bumped to v3.6.0 (removing v3.5.5).SummaryDifference0.5%

- Check14 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a newer version of the ClinicalTrials.gov record. This reflects a minor editorial or formatting update to the page rather than changes to study data or eligibility.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange Detected- Revision: v3.5.4 replaces v3.5.3 on the page, indicating a minor update to the page metadata. This change does not affect the study content, eligibility criteria, outcomes, or other substantive information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer now shows Revision: v3.5.3, replacing v3.5.2, indicating a small metadata update to the study record. This update does not modify the main study details or results.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision was updated to v3.5.0, replacing the previous v3.4.3 entry. This change is limited to metadata and does not alter the study content or user actions.SummaryDifference0.1%

Stay in the know with updates to Odanacatib Study in Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Odanacatib Study in Adolescents Clinical Trial page.